Miller Howard Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,194
Closed -$393K 141
2025
Q2
$393K Sell
16,194
-743
-4% -$17.3K 0.01% 129
2025
Q1
$429K Buy
16,937
+69
+0.4% +$1.81K 0.01% 133
2024
Q4
$448K Sell
16,868
-3,629
-18% -$98.4K 0.01% 134
2024
Q3
$593K Buy
20,497
+1,991
+11% +$58.1K 0.02% 149
2024
Q2
$518K Buy
18,506
+121
+0.7% +$3.33K 0.02% 151
2024
Q1
$510K Buy
18,385
+1,134
+7% +$31.5K 0.02% 156
2023
Q4
$497K Sell
17,251
-527
-3% -$15.9K 0.02% 153
2023
Q3
$590K Sell
17,778
-485
-3% -$17.2K 0.02% 139
2023
Q2
$670K Sell
18,263
-652
-3% -$25.4K 0.02% 143
2023
Q1
$772K Buy
18,915
+733
+4% +$31.7K 0.03% 140
2022
Q4
$932K Sell
18,182
-4
-0% -$192 0.03% 140
2022
Q3
$796K Buy
18,186
+195
+1% +$9.48K 0.03% 141
2022
Q2
$943K Buy
17,991
+3,634
+25% +$185K 0.04% 138
2022
Q1
$743K Sell
14,357
-106
-0.7% -$5.5K 0.03% 144
2021
Q4
$854K Buy
14,463
+122
+0.9% +$6.04K 0.03% 135
2021
Q3
$617K Sell
14,341
-3,726
-21% -$165K 0.03% 134
2021
Q2
$708K Sell
18,067
-815,465
-98% -$31.7M 0.03% 134
2021
Q1
$30.2M Sell
833,532
-12,274
-1% -$436K 1.27% 39
2020
Q4
$31.1M Sell
845,806
-36,019
-4% -$1.32M 1.47% 29
2020
Q3
$30.7M Sell
881,825
-53,451
-6% -$1.87M 1.62% 31
2020
Q2
$29M Sell
935,276
-136,507
-13% -$4.64M 1.45% 31
2020
Q1
$33.2M Sell
1,071,783
-133,223
-11% -$4.54M 1.7% 27
2019
Q4
$44.8M Sell
1,205,006
-51,675
-4% -$1.84M 1.41% 33
2019
Q3
$42.8M Sell
1,256,681
-840,785
-40% -$30.6M 1.33% 38
2019
Q2
$86.2M Sell
2,097,466
-150,853
-7% -$5.99M 2.53% 6
2019
Q1
$90.6M Sell
2,248,319
-113,108
-5% -$4.53M 2.5% 7
2018
Q4
$97.8M Sell
2,361,427
-80,576
-3% -$3.34M 2.86% 5
2018
Q3
$102M Sell
2,442,003
-72,164
-3% -$2.78M 2.47% 6
2018
Q2
$86.5M Sell
2,514,167
-71,821
-3% -$2.45M 2.08% 8
2018
Q1
$87.1M Buy
2,585,988
+298,616
+13% +$10.3M 2.06% 10
2017
Q4
$78.6M Sell
2,287,372
-181,177
-7% -$6.18M 1.71% 18
2017
Q3
$83.6M Buy
2,468,549
+369,962
+18% +$11.9M 1.72% 16
2017
Q2
$66.9M Sell
2,098,587
-75,745
-3% -$2.39M 1.33% 31
2017
Q1
$70.6M Sell
2,174,332
-785,764
-27% -$24.8M 1.36% 25
2016
Q4
$91.2M Sell
2,960,096
-143,769
-5% -$4.39M 1.75% 14
2016
Q3
$99.7M Sell
3,103,865
-113,887
-4% -$3.81M 1.83% 17
2016
Q2
$107M Sell
3,217,752
-129,433
-4% -$4.13M 1.93% 15
2016
Q1
$94.1M Buy
3,347,185
+1,020,659
+44% +$29.2M 1.74% 20
2015
Q4
$71.3M Sell
2,326,526
-186,446
-7% -$5.87M 1.28% 29
2015
Q3
$74.9M Sell
2,512,972
-77,427
-3% -$2.48M 1.24% 28
2015
Q2
$82.4M Buy
2,590,399
+463,500
+22% +$15.1M 1.11% 32
2015
Q1
$70.2M Buy
2,126,899
+58,158
+3% +$1.85M 1.06% 36
2014
Q4
$61.1M Buy
2,068,741
+62,102
+3% +$1.78M 0.94% 39
2014
Q3
$56.3M Buy
2,006,639
+10,971
+0.5% +$308K 0.87% 42
2014
Q2
$56.2M Buy
1,995,668
+1,637
+0.1% +$46.7K 0.89% 38
2014
Q1
$60.8M Buy
1,994,031
+17,668
+0.9% +$527K 1.11% 30
2013
Q4
$57.4M Sell
1,976,363
-4,690
-0.2% -$136K 1.15% 34
2013
Q3
$54M Buy
1,981,053
+38,959
+2% +$1.06M 1.16% 34
2013
Q2
$51.6M Buy
+1,942,094
New +$53.7M 1.19% 32

Other funds holding PFE

Miller Howard Investments's PFE Position: Q3 2025 in Review

Miller Howard Investments sold out of Pfizer (PFE) in Q3 2025, closing a stake of 16,194 shares — an estimated $393K sold.

Miller Howard Investments first reported a position in PFE in Q2 2013 and held it in 49 quarters. The position peaked at $107M in Q2 2016. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.

  • Miller Howard Investments reported no remaining Pfizer position as of Q3 2025 after selling out during the quarter.
  • Miller Howard Investments sold 16,194 Pfizer shares in Q3 2025, an estimated $393K.
  • Miller Howard Investments first reported a position in Pfizer in Q2 2013 and held it in 49 quarters.
  • Miller Howard Investments's Pfizer position peaked at $107M in Q2 2016.
  • 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.

Based on Miller Howard Investments's 13F filing for Q3 2025, filed 24 Oct 2025.